Jennifer L. Geurts

发表

Genomics in Clinical Practice: Lessons from the Front Lines

Jeremy M. Harris, H. Jacob, J. Lazar, 2013, Science Translational Medicine.

RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.

D. Largaespada, R. McIvor, A. Wilber, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes.

Jennifer L. Geurts, Erica L Blouch, P. Brock, 2020, Endocrine-related cancer.

Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines

F. Johnston, Jennifer L. Geurts, K. Strong, 2015, Familial Cancer.

Tubulopapillary adrenocortical adenoma in a patient with familial adenomatous polyposis: a morphologic, ultrastructural, and molecular study.

S. Rosati, Jennifer L. Geurts, A. Mackinnon, 2019, Human pathology.

Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.

P. Simpson, M. Nugent, D. Uyar, 2018, Gynecologic oncology.

Inherited syndromes involving pancreatic neuroendocrine tumors.

Jennifer L. Geurts, 2020, Journal of gastrointestinal oncology.

Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.

D. Largaespada, K. Shannon, L. Parada, 2007, Blood.

Hereditary Syndromes Involving Pheochromocytoma and Paraganglioma

Douglas B. Evans, Jennifer L. Geurts, Tracy S. Wang, 2016 .

Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype

D. Largaespada, S. Wiesner, Jennifer L. Geurts, 2011, American journal of hematology.

Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression.

D. Largaespada, L. Belur, R. McIvor, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Genetic Evaluation of the Patient with Medullary Thyroid Cancer

Jennifer L. Geurts, 2016 .

Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines

F. Johnston, Jennifer L. Geurts, K. Strong, 2015, Familial Cancer.

Gene Mutations and Genomic Rearrangements in the Mouse as a Result of Transposon Mobilization from Chromosomal Concatemers

L. Leinwand, R. Lucito, S. Lowe, 2006, PLoS genetics.

Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level

Michael T. Zimmermann, Douglas B. Evans, M. Zimmermann, 2021, Frontiers in Oncology.

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.

Jennifer L. Geurts, J. Neuner, Amanda L. Kong, 2016, American journal of surgery.

Genetic Counseling for Pancreatic Cancer

Jennifer L. Geurts, 2019, Management of Localized Pancreatic Cancer.

Development of a high risk pancreatic screening clinic using 3.0 T MRI

Douglas B. Evans, S. Tsai, K. Christians, 2017, Familial Cancer.

Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes

Sitao Wu, S. Domchek, Danielle B. McKenna, 2020, npj Precision Oncology.

Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2020, Surgery.

Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?

B. Erickson, Douglas B. Evans, S. Tsai, 2019, Journal of Gastrointestinal Surgery.

OVARIAN GRANULOSA CELL TUMOR IN A PATIENT WITH A PATHOGENIC VARIANT IN THE CDC73 GENE (HYPERPARATHYROIDISM-JAW TUMOR SYNDROME).

D. Uyar, Jennifer L. Geurts, J. Shaker, 2019, AACE clinical case reports.

Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency

Hanh T. Nguyen, D. Largaespada, K. Shannon, 2016, Haematologica.

Screening guidelines and recommendations for patients at high risk of developing endocrine cancers

Douglas B. Evans, Jennifer L. Geurts, Tracy S. Wang, 2020, Journal of surgical oncology.

Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

The Cost of Detecting Lynch Syndrome by Microsatellite Instability Testing in Community Practice: 1474

N. Vakil, A. Affi, Jennifer L. Geurts, 2010 .

Germline evaluation of patients undergoing tumor genomic profiling: An academic cancer center’s experience with implementing a germline review protocol

Michael T. Zimmermann, M. Zimmermann, Jennifer L. Geurts, 2021, Journal of genetic counseling.

Genomics in Clinical Practice: Lessons from the Front Lines

Jeremy M. Harris, H. Jacob, M. Shimoyama, 2013, Science Translational Medicine.

Uterine Sarcoma With a Novel WWOX-NTRK2 Fusion in a Postmenopausal Woman With Li-Fraumeni–Like Syndrome: A Case That Expands the Spectrum of NTRK-Rearranged Uterine Tumors

Jennifer L. Geurts, E. Bishop, Michelle Moh, 2021, AJSP: Reviews and Reports.

Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype

D. Largaespada, S. Wiesner, Jennifer L. Geurts, 2011, American journal of hematology/oncology.